Malignant neoplasm of prostate
|
0.400 |
Biomarker
|
disease |
CTD_human |
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.
|
24763052 |
2014 |
Neoplasm Metastasis
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling.
|
22580338 |
2012 |
Malignant neoplasm of stomach
|
0.400 |
Biomarker
|
disease |
CTD_human |
Collectively, these results suggest that nicotine stimulates gastric cancer cell growth through the activation of beta-adrenoceptors and the downstream PKC-betaI/ERK1/2/COX-2 pathway.
|
17003101 |
2007 |
Malignant neoplasm of lung
|
0.400 |
Biomarker
|
disease |
CTD_human |
Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
|
11884234 |
2002 |
Malignant neoplasm of lung
|
0.400 |
Biomarker
|
disease |
CTD_human |
Vanadium increases GLUT4 in diabetic rat skeletal muscle.
|
12083368 |
2002 |
Squamous cell carcinoma
|
0.390 |
Biomarker
|
disease |
CTD_human |
Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
|
21401805 |
2011 |
Malignant neoplasm of ovary
|
0.360 |
Biomarker
|
disease |
CTD_human |
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.
|
16211241 |
2005 |
Hyperalgesia
|
0.350 |
Biomarker
|
phenotype |
CTD_human |
Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.
|
27093858 |
2016 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
ERK1/2 mRNA expression was down-regulated in the depression model group compared with the normal control group (P<0.01).
|
21368416 |
2011 |
Depressive disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
ERK1/2 mRNA expression was down-regulated in the depression model group compared with the normal control group (P<0.01).
|
21368416 |
2011 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
|
20657013 |
2010 |
Depressive disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
|
20657013 |
2010 |
Depressive disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Although ERK1/2 has been proposed as a common mediator of antidepressant action in naive rodents, it remains to be determined whether the ERK1/2 pathway plays a role in depressive disorder.
|
19424057 |
2009 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
The intracellular factors by which ADTs and glucocorticoids, causal factors in depression, regulate depression-like behavior remain unclear, but extracellular signal-regulated kinase 1/2 (ERK1/2), upstream of CREB, is a likely candidate.
|
17889834 |
2008 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Mice lacking ERK1 exhibited enhanced fear extinction and reduced depression caused by overactivation of ERK2.
|
17712345 |
2008 |
Depressive disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
The intracellular factors by which ADTs and glucocorticoids, causal factors in depression, regulate depression-like behavior remain unclear, but extracellular signal-regulated kinase 1/2 (ERK1/2), upstream of CREB, is a likely candidate.
|
17889834 |
2008 |
Depressive disorder
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Mice lacking ERK1 exhibited enhanced fear extinction and reduced depression caused by overactivation of ERK2.
|
17712345 |
2008 |
Mental Depression
|
0.350 |
Biomarker
|
disease |
PSYGENET |
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.
|
15833803 |
2005 |
ovarian neoplasm
|
0.350 |
Biomarker
|
disease |
CTD_human |
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.
|
16211241 |
2005 |
Hyperalgesia
|
0.350 |
Biomarker
|
phenotype |
CTD_human |
Spinal ERK1/2 activation with capsaicin treatment correlated with the development of prolonged referred hyperalgesia.
|
12941468 |
2003 |
Cardiomyopathies
|
0.350 |
Therapeutic
|
group |
CTD_human |
Cocaine and apoptosis in myocardial cells.
|
10620750 |
1999 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
CTD_human |
Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.
|
30559488 |
2019 |
Schizophrenia
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.
|
25048004 |
2015 |
Schizophrenia
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Given the role of ERK1/2, alphaCaMKII and CREB in neuroplastic mechanisms and cell communication, our data suggest that their decreased activation following chronic PCP administration can contribute to cortical defects occurring in schizophrenia, and may therefore represent potential targets for pharmacological intervention.
|
18406625 |
2008 |
Lung Neoplasms
|
0.340 |
Biomarker
|
group |
CTD_human |
Vanadium increases GLUT4 in diabetic rat skeletal muscle.
|
12083368 |
2002 |